Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorderActive, not recruitingPhase 22024-11-14NCT05690204

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Shanton Pharma Pte. Ltd.2

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
California SiteSacramentoUnited States1
California SiteSan DiegoUnited States1
Denver SiteDenverUnited States1
Florida SiteDeBaryUnited States1
Florida SiteMiami LakesUnited States1
Florida SiteMiami LakesUnited States1
Florida SiteWinter ParkUnited States1
Florida SiteMiamiUnited States1
Idaho SiteBoiseUnited States1
Maryland SiteOxon HillUnited States1
Mississippi SiteJacksonUnited States1
North Carolina SiteRaleighUnited States1
Puerto Rico SiteSan JuanPuerto Rico1
Texas SitePlanoUnited States1
Texas SiteMesquiteUnited States1
Texas SiteThe WoodlandsUnited States1